Germano Geno J

Germano Geno J is listed in filings as Director at Precision BioSciences, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including purchase activity. Recent filings connect the profile to Precision BioSciences, Inc. (DTIL), Harmony Biosciences Holdings, Inc. (HRMY), Entera Bio Ltd. (ENTX), and Sage Therapeutics, Inc. (SAGE). The current snapshot covers public activity from Jun 11, 2024 to Jun 5, 2026. Reported amounts are shown as $653.1K to $29.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.